CLDX - Celldex Therapeutics, Inc.
IEX Last Trade
25.1
-0.320 -1.275%
Share volume: 4,750
Last Updated: Fri 27 Dec 2024 05:30:02 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$25.42
-0.32
-1.26%
Summary score
10%
Profitability
0%
Dept financing
2%
Liquidity
75%
Performance
5%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.02%
Return on assets
-7.08%
Return on sales
-7224.39%
Return on invested capital
-284.77%
Total debt ratio
8.12%
Debt ratio change over timeo
-1.1%
Current Ratio
18.39%
Quick Ratio
18.33%
Cash Position Ratio
17.17%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-10.13%
Return on assets
-9.51%
Return on sales
-10497.37%
Return on invested capital
-686.75%
Total debt ratio
7.64%
Debt ratio change over timeo
-1.02%
Current Ratio
17.85%
Quick Ratio
17.85%
Cash Position Ratio
17.39%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-3.91%
Return on assets
-4.67%
Return on sales
-26030.77%
Return on invested capital
-453.65%
Total debt ratio
3.48%
Debt ratio change over time
-1%
Current Ratio
31.77%
Quick Ratio
31.77%
Cash Position Ratio
31.34%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-92.64%
Return on assets
-93.47%
Return on sales
3923.1%
Return on invested capital
12.32%
Total debt ratio
-109.53%
Debt ratio change over time
-1.1%
Current Ratio
-20.27%
Quick Ratio
-16.91%
Cash Position Ratio
-17.01%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLDX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.02% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.08% | 2.76% | 3.15% | 5.62% |
| Return on sales | -7224.39% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -284.77% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 8.12% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.1% | 308.97% | -6.99% | 1.18% |
| Dept financing | 2% | 50% | 25% | 7% |
| Current Ratio | 17.85% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 17.85% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 17.39% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 6% | 14% |
| Short-term ratios | CLDX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.13% | 13.77% | 13.25% | 3.8% |
| Return on assets | -9.51% | 2.43% | 1.89% | 3.09% |
| Return on sales | -10497.37% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -686.75% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 7.64% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.02% | 46.38% | -72.08% | 1.51% |
| Dept financing | 2% | 50% | 25% | 7% |
| Current Ratio | 17.85% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 17.85% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 17.39% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 7% | 18% |